Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis